~~<i id='BE5C7D6693'><strike id='BE5C7D6693'><tt id='BE5C7D6693'><pre id='BE5C7D6693'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：explore 2025-10-01 14:59:37 - browse：94

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： ActiGraph execs on goal of drug approvals with digital endpoints

hotspot

Wikipedia

focus

explore

focus

hotspot

AdobeTherearepeopleinyourlifewhoinfluenceandshapehowyouseetheworld.Forme,oneofthesepeopleisTerryMoak

WSS

Black vets could get higher VA benefits if race not used in lung test

How a small hospital in rural Puerto Rico survived Hurricane Maria

Eye stem cell transplant could help restore vision in injured people

Most antidepressants don't work on kids, teens, study finds

Patient advocates sound warning on FDA proposal on salt intake

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

leisure time

Wikipedia

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

ProMED sees offers of support, but its future remains unclear

Hepatitis C has a cure — but many Americans still lack access to it

Novel spinal cord stimulator treats paralysis without surgery

Malaria cases in Florida and Texas: Here’s what you need to know

Is it ever OK for doctors to lie to their patients?

The cancer drug shortage isn’t new — and neither are the solutions

As health system earnings go up, health insurance stocks go down

Psychedelics group wrestles with new pharma identity

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Wikipedia

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Hilary may become 1st tropical storm to make landfall in California in 84 years

Most antidepressants don't work on kids, teens, study finds

Lung cancer is America's deadliest cancer. Yet so few get screened

FDA approves first treatment for ultra

How a small hospital in rural Puerto Rico survived Hurricane Maria

focus

explore

focus

hotspot